1,5-dimethylbenzo-1H-triazole | 101257-51-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并三唑类
• 英文名称: 1,5-dimethylbenzo-1H-triazole
• 英文别名: 1,5-dimethyl-1H-benzotriazole；1,5-Dimethyl-1H-benzotriazol；1,5-Dimethyl-1H-benzo[d][1,2,3]triazole；1,5-dimethylbenzotriazole
• CAS: 101257-51-6
• 化学式: C₈H₉N₃
• 分子量: 147.18
• InChiKey: CFOHWVICEQOSOZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  30.7
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  (9ci)-1,5-二甲基-1H-苯并咪唑 在 lead(IV) acetate 、 盐酸 、 2,4-二硝基苯基羟胺 作用下， 以 甲醇 为溶剂， 反应 24.5h， 生成 1,5-dimethylbenzo-1H-triazole
  参考文献：
  名称：

  7-氨基-9-乙基鸟嘌呤和1-氨基-3-甲基苯并咪唑的氯化物盐与乙酸铅（IV）的反应：形成8-氮杂-9-乙基鸟嘌呤和1-甲基-1H-苯并三唑。

  摘要：

  氯化7-氨基-9-乙基鸟嘌呤与乙酸铅（IV）（MeOH）在MeOH中的反应生成8-氮杂-9-乙基鸟嘌呤。同样，1-氨基-3-甲基苯并咪唑氯化物或其取代的衍生物（6-甲基，5,6-二甲基和5-硝基）与LTA反应，得到相应的1-甲基-1H-苯并三唑（或1-甲基- 2-氮杂苯并咪唑衍生物）和N-甲基甲酰苯胺衍生物。

  DOI：

  10.1016/s0960-894x(99)00123-7

文献信息

• Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20150231142A1

  公开（公告）日：2015-08-20

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及含有上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• [EN] HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF STRESS-RELATED CONDITIONS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES POUR LE TRAITEMENT D'ÉTATS LIÉS AU STRESS
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2010137738A1

  公开（公告）日：2010-12-02

  The present invention provides a novel heterocyclic compound. A heterocyclic compound represented by general formula (1) wherein, R1 and R2, each independently represent hydrogen; a phenyl lower alkyl group that may have a substituent(s) selected from the group consisting of a lower alkyl group and the like on a benzene ring and/or a lower alkyl group; or a cyclo C3-C8 alkyl lower alkyl group; or the like; R3 represents a lower alkynyl group or the like; R4 represents a phenyl group that may have a substituent(s) selected from the group consisting of a 1,3,4-oxadiazolyl group that may have e.g., halogen or a heterocyclic group selected from pyridyl group and the like; the heterocyclic group may have at least one substituent(s) selected from a lower alkoxy group and the like or a salt thereof.

  本发明提供了一种新颖的杂环化合物。一种由通式（1）表示的杂环化合物，其中，R1和R2分别独立表示氢；苯基较低烷基基团，可能在苯环和/或较低烷基基团上具有从较低烷基基团等组成的取代基；或环C3-C8烷基较低烷基基团；或类似物；R3表示较低炔基基团或类似物；R4表示可能具有从1,3,4-噁二唑基团（例如，卤素）或从吡啶基团等组成的取代基的苯基团；所述杂环基可能具有至少一个从较低烷氧基等选择的取代基或其盐。
• COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
  申请人：Van Goor Fredrick F.

  公开号：US20110098311A1

  公开（公告）日：2011-04-28

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及包含上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• [EN] NOVEL BIS-AMIDES AS ANTIMALARIAL AGENTS<br/>[FR] NOUVEAUX BISAMIDES EN TANT QU'AGENTS ANTIPALUDIQUES
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2010058353A1

  公开（公告）日：2010-05-27

  The invention relates to novel bis-amide derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing one or more of those compounds and their use as medicaments for the treatment or prevention of protozoal infections, such as especially malaria.

  这项发明涉及新型双酰胺衍生物及其在制备药物组合物中作为活性成分的用途。该发明还涉及相关方面，包括含有其中一种或多种化合物的药物组合物以及它们作为药物治疗或预防原虫感染的用途，尤其是疟疾。
• NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS
  申请人：Aissaoui Hamed

  公开号：US20110224210A1

  公开（公告）日：2011-09-15

  The invention relates to novel bis-amide derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing one or more of those compounds and their use as medicaments for the treatment or prevention of protozoal infections, such as especially malaria.

  这项发明涉及新型双酰胺衍生物及其在制备药物组合物中作为活性成分的用途。该发明还涉及相关方面，包括含有这些化合物中的一个或多个的药物组合物以及它们作为治疗或预防原虫感染的药物，尤其是疟疾的用途。